Moderna says its Covid-19 shot remains 93% effective 4-6 months after second dose


NEW YORK (Reuters): Moderna Inc said on Thursday (Aug 5) its Covid-19 shot was about 93% effective four to six months after the second dose, showing hardly any change from the 94% efficacy reported in its original clinical trial.

That compares favourably to data released by rivals Pfizer Inc and BioNTech SE last week in which they suggested their vaccine's efficacy waned around 6% every two months, declining to around 84% six months after the second shot. Both the Moderna and Pfizer-BioNTech vaccines are based on messenger RNA (mRNA) technology.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Aseanplus News

Blinken to attend G7 meeting in Italy, US State Department says
'Abang Adik' wins Best Film at the 10th Asian World Film Festival held in Los Angeles
Dr Wee is set to address key issues at the 11th GLA Conference in Bangkok
Asean News Headlines at 10pm on Friday (Nov 22, 2024)
Aaron-Wooi Yik, Pearly Thinaah bow out of China Masters
Japan government approves mammoth US$140bil stimulus with aims putting more cash into peoples' pocket
Man killed after public place shooting in Sydney's inner city
Gold bars, cash bundles in kimchi boxes: Millions seized from S. Korea tax dodgers
Action star Jackie Chan recalls earning his first HK$4mil pay cheque and buying 7 luxury watches in one go
Singapore raises 2024 growth forecast as recovery takes hold in good manner this year

Others Also Read